Form 4: Scientific Industries Director Acquires Options in Lieu of Cash Compensation

Michael Blechman, a director at Scientific Industries, acquired options to purchase common stock as part of an agreement to receive fees in lieu of cash compensation.

Summary

• On May 17, 2024, Michael Blechman, a director of Scientific Industries Inc., acquired options to purchase 25,000 shares of common stock at an exercise price of $1.75.
• These options vest in three equal installments starting May 17, 2024, and expire on May 17, 2034.
• Blechman also acquired options to purchase 7,186 shares of common stock at an exercise price of $2.50 as part of an agreement to receive fees in lieu of cash compensation.
• These options vest in twelve monthly installments commencing on May 17, 2024, through May 17, 2025.
• Following these transactions, Blechman directly owns 32,186 derivative securities.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The director taking options in lieu of cash is a good sign, but there is a potential dilution risk.

Positives

• The director's acceptance of options in lieu of cash compensation may be viewed positively as it conserves the company's cash resources.
• The vesting schedules of the options align the director's interests with the long-term performance of the company.

Risks

• The exercise of these options could potentially dilute existing shareholders' equity.

Industry Context

This type of equity compensation is common in publicly traded companies to align the interests of directors and management with those of shareholders.

Comparison to Industry Standards

• Equity compensation for board members is a common practice across various industries.
• Companies like Thermo Fisher Scientific and Danaher Corporation also utilize stock options and restricted stock units as part of their director compensation packages.
• The vesting schedules and exercise prices are generally determined based on industry benchmarks and company-specific performance metrics.

Related Party Transactions

• The agreement between the Reporting Person and the Issuer to elect to be paid part of his fees in lieu of cash compensation is a related party transaction.

Stakeholder Impact

• Shareholders may experience potential dilution if the options are exercised.
• The company benefits from conserving cash by issuing options instead of cash compensation.

Key Dates

Keywords

options, director, Scientific Industries, SCND, Form 4, beneficial ownership, Michael Blechman, compensation